Harris Kaplan interviewed in September issue of PharmaVoicePrint this Page

The article “Nichebusters vs. Blockbusters” presents views from industry leaders focusing on “Following the science instead of the money will warrant a radical shift in commercial model strategies.”

Click here to read the article.